SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-184966
Filing Date
2021-06-08
Accepted
2021-06-08 07:44:03
Documents
20
Period of Report
2021-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d358413d8k.htm   iXBRL 8-K 35091
2 EX-4.1 d358413dex41.htm EX-4.1 84357
3 EX-4.2 d358413dex42.htm EX-4.2 82656
4 EX-5.1 d358413dex51.htm EX-5.1 8474
5 EX-10.1 d358413dex101.htm EX-10.1 192838
6 EX-10.3 d358413dex103.htm EX-10.3 8263
7 EX-99.1 d358413dex991.htm EX-99.1 12410
11 GRAPHIC g358413dsp94.jpg GRAPHIC 3754
12 GRAPHIC g358413g0608024218256.jpg GRAPHIC 7398
  Complete submission text file 0001193125-21-184966.txt   679221

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hsto-20210607.xsd EX-101.SCH 3077
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20210607_lab.xml EX-101.LAB 18137
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20210607_pre.xml EX-101.PRE 11412
13 EXTRACTED XBRL INSTANCE DOCUMENT d358413d8k_htm.xml XML 3357
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 211001261
SIC: 2834 Pharmaceutical Preparations